Medtronic delivers $36 billion in revenue with strong top-line growth
Medtronic raised its dividend for the 49th consecutive year, with $36 billion in revenue marking its strongest top-line growth in 10 years.
The company’s diversified medical device business, organized into four portfolios, helps mitigate risks.
Medtronic’s revenue reached $36.36 billion in fiscal 2026, up 8.43% year over year, driven in part by its Cardiovascular segment, which produced $3.80 billion.
The company’s defensive value and non-discretionary procedures insulate it from market downturns, despite near-term risks like a $185 million tariff headwind and margin compression.